The authors apologize that the original version of the above article contains errors that need to be corrected. Incorrect images for Figure 3G were used during figure assembly. The correction does not affect the conclusions of the above paper. The authors sincerely apologize for any inconvenience these errors may have caused. The corrected Figure 3G appears below.
. 2022 Nov 2;12(17):7645. doi: 10.7150/thno.78949
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum
Hui-Juan Liu
1,2,✉,*, Yuan Qin
1,2,*, Zi-Han Zhao
1,2,*, Yang Zhang
4,*, Jia-Huan Yang
1,2, Deng-Hui Zhai
1,2, Fang Cui
1,2, Ce Luo
1, Man-Xi Lu
1, Piao-Piao Liu
1, Heng-Wei Xu
1,2, Kun Li
1,2, Bo Sun
2, Shuang Chen
2, Hong-Gang Zhou
1,✉, Cheng Yang
1,2,✉, Tao Sun
1,2,3,✉
Hui-Juan Liu
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Hui-Juan Liu
Yuan Qin
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Yuan Qin
Zi-Han Zhao
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Zi-Han Zhao
Yang Zhang
4Department of Anesthesiology, Tianjin Fourth Central Hospital, Tianjin, China.
Find articles by Yang Zhang
Jia-Huan Yang
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Jia-Huan Yang
Deng-Hui Zhai
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Deng-Hui Zhai
Fang Cui
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Fang Cui
Ce Luo
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
Find articles by Ce Luo
Man-Xi Lu
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
Find articles by Man-Xi Lu
Piao-Piao Liu
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
Find articles by Piao-Piao Liu
Heng-Wei Xu
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Heng-Wei Xu
Kun Li
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Kun Li
Bo Sun
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Bo Sun
Shuang Chen
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Shuang Chen
Hong-Gang Zhou
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
Find articles by Hong-Gang Zhou
Cheng Yang
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Find articles by Cheng Yang
Tao Sun
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
3Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China.
Find articles by Tao Sun
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
2Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
3Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China.
4Department of Anesthesiology, Tianjin Fourth Central Hospital, Tianjin, China.
✉
✉ Corresponding authors: Tao Sun, E-mail: tao.sun@nankai.edu.cn; Cheng Yang, E-mail: cheng.yang@nankai.edu.cn; Hong-gang Zhou, E-mail: honggang.zhou@nankai.edu.cn; Hui-juan Liu, E-mail: liuhuijuanxyz@163.com.
*These authors have contributed equally to this work.
Collection date 2022.
© The author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
PMCID: PMC9691362 PMID: 36438475
This corrects the article "Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway" in volume 10 on page 9083.